TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma.

MLA

Shi, Bingqing, et al. “TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma.” Frontiers in Immunology, vol. 13, Apr. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fimmu.2022.883885.

APA

Shi, B., Hao, Y., Li, W., Dong, H., Xu, M., & Gao, P. (2022). TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma. Frontiers in Immunology, 13, 1–13. https://doi.org/10.3389/fimmu.2022.883885

Chicago

Shi, Bingqing, Yuqiu Hao, Wei Li, Hongna Dong, Mengting Xu, and Peng Gao. 2022. “TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma.” Frontiers in Immunology 13 (April): 1–13. doi:10.3389/fimmu.2022.883885.